AU7106400A - Fluorescent dye angiography and dye-enhanced photocoagulation - Google Patents

Fluorescent dye angiography and dye-enhanced photocoagulation

Info

Publication number
AU7106400A
AU7106400A AU71064/00A AU7106400A AU7106400A AU 7106400 A AU7106400 A AU 7106400A AU 71064/00 A AU71064/00 A AU 71064/00A AU 7106400 A AU7106400 A AU 7106400A AU 7106400 A AU7106400 A AU 7106400A
Authority
AU
Australia
Prior art keywords
dye
angiography
fluorescent
enhanced photocoagulation
photocoagulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71064/00A
Inventor
Abu Alam
Robert W. Flower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akorn Operating Co LLC
Original Assignee
Akorn Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/393,456 external-priority patent/US6351663B1/en
Application filed by Akorn Inc filed Critical Akorn Inc
Publication of AU7106400A publication Critical patent/AU7106400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0097—Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU71064/00A 1999-09-10 2000-09-05 Fluorescent dye angiography and dye-enhanced photocoagulation Abandoned AU7106400A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/393,456 US6351663B1 (en) 1999-09-10 1999-09-10 Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
US09393456 1999-09-10
US48797700A 2000-01-20 2000-01-20
US09487977 2000-01-20
PCT/US2000/024160 WO2001017561A1 (en) 1999-09-10 2000-09-05 Fluorescent dye angiography and dye-enhanced photocoagulation

Publications (1)

Publication Number Publication Date
AU7106400A true AU7106400A (en) 2001-04-10

Family

ID=27014298

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71064/00A Abandoned AU7106400A (en) 1999-09-10 2000-09-05 Fluorescent dye angiography and dye-enhanced photocoagulation

Country Status (2)

Country Link
AU (1) AU7106400A (en)
WO (1) WO2001017561A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6944493B2 (en) * 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6915154B1 (en) 1999-09-24 2005-07-05 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US20050182434A1 (en) 2000-08-11 2005-08-18 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US20060239921A1 (en) 2005-04-26 2006-10-26 Novadaq Technologies Inc. Real time vascular imaging during solid organ transplant
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
DE102006030382A1 (en) * 2006-06-29 2008-01-03 Carl Zeiss Meditec Ag Method and device for optical detection on the eye
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
EP2285421B1 (en) 2008-05-02 2018-04-11 Novadaq Technologies ULC Methods for production and use of substance-loaded erythrocytes for observation and treatment of microvascular hemodynamics
US8144958B2 (en) 2008-09-11 2012-03-27 Carl Zeiss Meditec Ag Medical systems and methods
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
JP6028096B2 (en) 2012-06-21 2016-11-16 ノバダック テクノロジーズ インコーポレイテッド Angiography and perfusion quantification and analysis techniques
CN107209118B (en) 2014-09-29 2021-05-28 史赛克欧洲运营有限公司 Imaging of target fluorophores in biological materials in the presence of autofluorescence
KR102012880B1 (en) 2014-10-09 2019-08-22 노바다크 테크놀러지즈 유엘씨 Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
JP6931705B2 (en) 2017-02-10 2021-09-08 ノバダック テクノロジーズ ユーエルシー Open Field Handheld Fluorescence Imaging Systems and Methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798349A (en) * 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
CA2536069C (en) * 1994-03-14 2008-06-03 Massachusetts Eye And Ear Infirmary Use of green porphyrins in ocular diagnosis and therapy
JP3845469B2 (en) * 1996-02-21 2006-11-15 明治製菓株式会社 Administration agent for occlusion of neovascularization of the fundus
AU727138B2 (en) * 1996-06-04 2000-12-07 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
CA2356532A1 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy

Also Published As

Publication number Publication date
WO2001017561A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
AU6206800A (en) Bridged fluorescent dyes, their preparation and their use in assays
AU7651400A (en) Fluorescent maleimides and uses thereof
AU7106400A (en) Fluorescent dye angiography and dye-enhanced photocoagulation
AU2003259769A1 (en) Bifunctional contrast agent comprising a fluorescent dye and an mri contrast agent
AU2361901A (en) New colouring combination
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
AU3620600A (en) Skin-marking devices and their use
AU3957900A (en) New compounds, their preparation and use
IL149798A0 (en) Near infrared fluorescent contrast agent
AU2002222774A1 (en) Oilcloth and lamp black
AU2002247715A1 (en) Rylene derivatives and their use as dyes
AU1863701A (en) Dye fixing composition
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU2425399A (en) Fluorescent dye
EP1469001B8 (en) Corroles, including chiral derivatives and the use thereof
HK1041200A1 (en) Cyclopentanone derivatives and their use
AU2002306620A1 (en) Fluorescent dye
AU6612300A (en) Ophthalmoscope attachment
AU3328600A (en) Ocular tension-lowering agents
AU3155201A (en) New colouring combination
AU2003226664A1 (en) Blue 3h-naphtho-(2,1-b)-pyran derivatives and use thereof
AU7026100A (en) Dye compositions and uses
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase